These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 29959959)

  • 21. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
    Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P
    Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
    Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
    ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.
    Maeki M; Kimura N; Sato Y; Harashima H; Tokeshi M
    Adv Drug Deliv Rev; 2018 Mar; 128():84-100. PubMed ID: 29567396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery.
    Lamichhane TN; Raiker RS; Jay SM
    Mol Pharm; 2015 Oct; 12(10):3650-7. PubMed ID: 26376343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review on the modifications of extracellular vesicles: a revolutionized tool of nano-biotechnology.
    Raghav A; Jeong GB
    J Nanobiotechnology; 2021 Dec; 19(1):459. PubMed ID: 34965878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches to surface engineering of extracellular vesicles.
    Richter M; Vader P; Fuhrmann G
    Adv Drug Deliv Rev; 2021 Jun; 173():416-426. PubMed ID: 33831479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular vesicles in cardiovascular disease.
    Huang C; Neupane YR; Lim XC; Shekhani R; Czarny B; Wacker MG; Pastorin G; Wang JW
    Adv Clin Chem; 2021; 103():47-95. PubMed ID: 34229852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of serum extracellular vesicles for novel small molecule inhibitor cell delivery.
    Hatzidaki E; Vlachou I; Elka A; Georgiou E; Papadimitriou M; Iliopoulos A; Papasotiriou I
    Anticancer Drugs; 2019 Mar; 30(3):271-280. PubMed ID: 30489291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles.
    Iraci N; Leonardi T; Gessler F; Vega B; Pluchino S
    Int J Mol Sci; 2016 Feb; 17(2):171. PubMed ID: 26861302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering and loading therapeutic extracellular vesicles for clinical translation: A data reporting frame for comparability.
    Piffoux M; Volatron J; Cherukula K; Aubertin K; Wilhelm C; Silva AKA; Gazeau F
    Adv Drug Deliv Rev; 2021 Nov; 178():113972. PubMed ID: 34509573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosing extracellular vesicles.
    Gupta D; Zickler AM; El Andaloussi S
    Adv Drug Deliv Rev; 2021 Nov; 178():113961. PubMed ID: 34481030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles.
    Kumar A; Zhou L; Zhi K; Raji B; Pernell S; Tadrous E; Kodidela S; Nookala A; Kochat H; Kumar S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging strategies for labeling and tracking of extracellular vesicles.
    Li YJ; Wu JY; Wang JM; Hu XB; Xiang DX
    J Control Release; 2020 Dec; 328():141-159. PubMed ID: 32882270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.
    Surman M; Drożdż A; Stępień E; Przybyło M
    Curr Pharm Des; 2019; 25(2):132-154. PubMed ID: 30848183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.
    Zarà M; Guidetti GF; Camera M; Canobbio I; Amadio P; Torti M; Tremoli E; Barbieri SS
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.